OverviewSuggest Edit

LGC is a company engaged in the life science tools sector. It provides mission critical components to customers across clinical diagnostics, pharmaceutical, research and government, food, and other applied markets.

TypePrivate
Founded1842
HQTeddington, GB
Websitelgcgroup.com
Employee Ratings3.3

Latest Updates

Employees (est.) (Sept 2016)901
Job Openings25
Revenue (FY, 2018)£131.2 M(+8%)
Cybersecurity ratingBMore

Key People/Management at LGC

Tim Robinson

Tim Robinson

Chief Executive Officer and Director
Simon Parsons

Simon Parsons

Chief Financial Officer, Director
Euan O'Sullivan

Euan O'Sullivan

Chief Operating Officer and Director
Supraj Rajagopalan

Supraj Rajagopalan

Non Executive Director
Tish S Creasey

Tish S Creasey

Non Executive Director
Judy C. Lewent

Judy C. Lewent

Non Executive Director
Show more

LGC Office Locations

LGC has offices in Teddington, Bellshill, Hoddesdon, Kidlington and in 25 other locations
Teddington, GB (HQ)
Queen's Rd
Bellshill, GB
Mallard Way
Hoddesdon, GB
Unit 1-2, Trident Industrial Estate, Pindar Rd
Lancashire, GB
1 Chamberhall Green
London, GB
Ground Floor, Minerva House, 5 Montague Cl
Sandwich, GB
Ramsgate Rd
Show all (32)

LGC Financials and Metrics

Summary Metrics

Founding Date

1842

LGC investors

Show all financial metrics

LGC Revenue

LGC's revenue was reported to be £131.22 m in FY, 2018
GBP

Revenue (FY, 2018)

131.2m

Net income (FY, 2018)

9.2m

EBITDA (FY, 2018)

(2.6m)

EBIT (FY, 2018)

(8.4m)

Cash (31-Mar-2018)

10.3m
GBPFY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

15.0m14.7m16.1m19.2m21.4m24.9m38.0m40.8m47.2m50.2m52.0m66.0m79.1m83.3m79.5m86.3m96.1m98.3m99.4m103.2m122.0m131.2m

Revenue growth, %

4%

Operating expense total

14.8m14.4m15.8m18.3m20.3m23.5m35.1m39.0m43.0m44.6m76.2m71.4m73.5m89.2m92.3m91.7m105.9m122.2m139.6m

EBITDA

10.4m11.4m16.9m11.9m12.3m13.7m3.3m5.8m(2.6m)
GBPFY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

2.3m2.3m3.7m2.9m4.8m3.7m3.2m1.9m156.0k3.9m5.7m10.9m1.4m1.4m6.3m3.5m5.5m8.7m8.6m22.9m10.3m

Accounts Receivable

1.5m1.8m2.2m2.3m3.2m4.4m5.1m4.4m7.1m6.0m7.5m15.0m11.1m10.6m11.5m11.4m10.0m12.8m13.1m14.6m18.1m9.5m

Inventories

642.0k660.0k768.0k798.0k833.0k1.8m1.7m976.0k591.0k957.0k880.0k1.0m1.5m1.5m1.7m2.3m1.9m3.6m4.2m4.8m7.1m5.6m

Current Assets

8.0m7.8m7.6m7.6m10.9m11.0m13.0m12.5m13.8m37.7m41.5m42.5m45.7m25.4m28.5m40.9m42.5m61.5m93.7m128.2m174.5m283.9m
GBPFY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

237.0k477.0k407.0k747.0k923.0k1.0m2.7m1.4m4.7m13.7m889.0k5.0m4.9m(1.0m)2.0m4.5m5.6m4.3m12.6m(6.1m)(6.0m)9.2m

Cash From Operating Activities

3.7m411.0k

Dividends Paid

160.0k310.0k483.0k816.0k500.0k500.0k1.0m8.1m

Cash From Financing Activities

11.5m
GBPFY, 1997

Financial Leverage

1.5 x
Show all financial metrics

LGC Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

LGC Online and Social Media Presence

Embed Graph

LGC News and Updates

Scott+Scott Attorneys at Law LLP Investigates Legacy Acquisition Corp’s Directors and Officers for Breach of Fiduciary Duties – LGC, ID

NEW YORK, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of Legacy Acquisition Corp (“Legacy Acquisition”) (NYSE: LGC), now known as Parts i…

OliX Pharmaceuticals Signs Agreement with LGC Biosearch Technologies to Accelerate Production of Asymmetric siRNA for the Treatment of Androgenic Alopecia

SEOUL, Republic of Korea and LONDON, June 09, 2021 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, and LGC, a global leader in the life science tools sector headquartered in London, announced that the companies signed an exclusive contract…

LGC Announces COVID-19 Antibody Assay Processes up to 40,000 Tests Per Day in UK

LOS ANGELES and CAMBRIDGE, England, Sept. 23, 2020 /PRNewswire/ -- LGC's Immunogenicity Centre of Excellence has successfully developed a COVID-19 antibody assay that is suitable for both serum and dried blood sampling. LGC's new assay can analyze up to 40,000 samples per day using serum...

OliX Pharmaceuticals Signs Agreement with LGC Biosearch Technologies to Accelerate Production of Asymmetric siRNA for the Treatment of Sub-Retinal Fibrosis and Wet Macular Degeneration

SUWON, Republic of Korea and LONDON, June 16, 2020 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company signed an exclusive contract with LGC Biosearch Technologies Inc. (LGC), a contract development and manufac…

LGC Frequently Asked Questions

  • When was LGC founded?

    LGC was founded in 1842.

  • Who are LGC key executives?

    LGC's key executives are Tim Robinson, Simon Parsons and Euan O'Sullivan.

  • How many employees does LGC have?

    LGC has 901 employees.

  • What is LGC revenue?

    Latest LGC annual revenue is £131.2 m.

  • What is LGC revenue per employee?

    Latest LGC revenue per employee is £145.6 k.

  • Who are LGC competitors?

    Competitors of LGC include Genetic Analysis Strategies, Jena Bioscience and Elicityl.

  • Where is LGC headquarters?

    LGC headquarters is located at Queen's Rd, Teddington.

  • Where are LGC offices?

    LGC has offices in Teddington, Bellshill, Hoddesdon, Kidlington and in 25 other locations.

  • How many offices does LGC have?

    LGC has 32 offices.